Current applications of monoclonal antibodies for the therapy of hematopoietic cancers
- 31 October 1991
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 3 (5) , 679-684
- https://doi.org/10.1016/0952-7915(91)90096-j
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibodyBlood, 1991
- Man-made antibodiesNature, 1991
- Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoidesBlood, 1991
- Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1990
- Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysisBlood, 1990
- Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.The Journal of Experimental Medicine, 1989
- Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotypeBlood, 1989
- REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1HThe Lancet, 1988
- Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.Journal of Clinical Oncology, 1988
- Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.Journal of Clinical Oncology, 1987